Rouen Normandy University
Also known as: CHU de Rouen | CHU de ROUEN | CHU de Rouen - Accueil | CHU-Hôpitaux de Rouen - Hôpital de Bois-Guillaume, Service de pneumologie, Bois-Guillaume, France | CHU-Hôpitaux de Rouen - Service de pneumologie, Hôpital de Bois-Guillaume, Rouen, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France | chu Rouen | CHU Rouen | clinique dermatologique du chu de Rouen | CRFDP (University of Rouen) | Departement of Anesthesia, University Hospital, Rouen | Hopital Charles Nicolle | HOPITAL CHARLES NICOLLE - ROUEN | HOPITAL CHARLES NICOLLE, ROUEN | HOPITAL CHARLES NICOLLE - ROUEN CEDEX | Hôpital Claude-Huriez | HOPITAL CLAUDE HURIEZ- LILLE CEDEX | Normandie University, UNIROUEN, UPRES EA 3830, Haute Normandie Research and Biomedical Innovation, Rouen, France ; Pulmonary, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France | Rouen (FR), University College Hospital | Rouen university Hospital | Rouen University Hospital | UH Rouen | UH-Rouen | UMR_S 1077 Inserm-EPHE-Normandie Université | University hopsital of Rouen | University Hospital of Rouen | University Hospital of Rouen, France: | University Hospital, Rouen | University of Rouen | University of Rouen Normandie
Highest phase reached
Phase 4
First clinical trial
Jul 1, 1997Last known activity
Nov 5, 2025
Timeline
1600s
- Jan 1, 1602
Rouen Normandy University— Founded
Drugs by trial phase (129 distinct, 111 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (65 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Acute Pain
- Adenocarcinoma
- Alopecia
- Alopecia Areata
- Anorexia
- Anorexia Nervosa
- Antiphospholipid Syndrome
- Arteritis
- Arthritis
- Arthritis, Rheumatoid
- Autoimmune Diseases
- Brain Ischemia
- Carcinoma, Ductal
- Carcinoma, Non-Small-Cell Lung
- Colonic Neoplasms
- Congenital Abnormalities
- Dermatitis
- Dermatitis, Seborrheic
- Diabetes Mellitus
- Drug Hypersensitivity
- Emergencies
- Endometriosis
- Esophageal Neoplasms
- Fecal Incontinence
- Gastrointestinal Hemorrhage
- Giant Cell Arteritis
- Hemophilia A
- Hemorrhage
- Hyperparathyroidism
- Hypersensitivity
- Hypertension
- Intestinal Obstruction
- Intracranial Hemorrhages
- Ischemia
- Leukomalacia, Periventricular
- Lung Neoplasms
- Muscular Dystrophies
- Muscular Dystrophy, Oculopharyngeal
- Obesity
- Obesity, Morbid
- Parkinson Disease
- Pemphigoid, Benign Mucous Membrane
- Pemphigoid, Bullous
- Pemphigus
- Placenta Previa
- Pneumonia
- Polymyalgia Rheumatica
- Premature Birth
- Prolapse
- Psoriasis
- Psychomotor Agitation
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Retinal Neoplasms
- Retinoblastoma
- Shock
- Shock, Septic
- Stomatitis
- Stomatitis, Aphthous
- Syndrome
- Urinary Bladder Neoplasms
- Urinary Bladder, Overactive
- Urticaria
- Vision Disorders
Recent trials (50)
- NCT07030803CollaboratorN/ANov 5, 2025
- NCT07044453Lead sponsorPhase 2/Phase 3Sep 30, 2025
- NCT06881966Lead sponsorN/ASep 1, 2025
- NCT06881966Sponsor investigatorN/ASep 1, 2025
- NCT07037043CollaboratorPhase 3Aug 31, 2025
- NCT06822751Lead sponsorPhase 3Jun 30, 2025
- NCT07259655Lead sponsorPhase 4Mar 6, 2025
- NCT07259655Sponsor investigatorPhase 4Mar 6, 2025
- NCT06695962Lead sponsorPhase 3Mar 1, 2025
- NCT06291103Lead sponsorPhase 2/Phase 3Jan 1, 2025
- NCT06649227CollaboratorPhase 1Jan 1, 2025
- NCT06291077Lead sponsorPhase 4Jan 1, 2025
- NCT06291116Lead sponsorPhase 2Jan 1, 2025
- NCT06731647CollaboratorPhase 2Nov 12, 2024
- NCT06585020CollaboratorPhase 2Oct 31, 2024
Details
- Founded
- Rouen, FR Jan 1, 1602
- Last known activity
- Nov 5, 2025
Notes
--- Pre-folding founded info: 1996-06-01 Rouen FR https://en.wikipedia.org/wiki/University_of_Rouen ---